GLENMARK PHARMACEUTICALS LTD. - Closure of Trading Window

The Company has intimated its Directors and other Designated Persons regarding closure of trading window from December 31, 2023 to February 16, 2024 (both days inclusive) for the purpose of approval of Unaudited Financial Results for the Third Quarter and Nine Months ended December 31, 2023